Insmed to present at the nasdaq 47th investor conference

Bridgewater, n.j. , nov. 30, 2022 /prnewswire/ -- insmed incorporated (nasdaq:insm), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the nasdaq 47th investor conference in london on wednesday, december 7 at 8:30 a.m.
INSM Ratings Summary
INSM Quant Ranking